Anika Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $330.7M
Liabilities Breakdown FY2019
Total Liabilities: $42.3M
Asset Breakdown
Total Assets: $330.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $157.5M | 47.6% |
| Accounts Receivable | $23.1M | 7.0% |
| Inventory | $22.0M | 6.7% |
| Property, Plant & Equipment | $50.8M | 15.4% |
| Goodwill | $7.7M | 2.3% |
| Intangible Assets | $7.6M | 2.3% |
| Other Assets | $62.1M | 18.8% |
Liabilities Breakdown
Total Liabilities: $42.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.8M | 9.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $38.5M | 90.9% |